Orchestra BioMed Ownership | Who Owns Orchestra BioMed?
Orchestra BioMed Ownership Summary
Orchestra BioMed is owned by 47.23% institutional investors, 16.19% insiders, and 36.58% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 21.63% of OBIO shares.
OBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Orchestra BioMed | 47.23% | 16.19% | 36.58% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 8.31M | 21.63% | $22.26M |
| Perceptive advisors | 4.59M | 11.96% | $12.31M |
| Blackrock funding, inc. /de | 681.35K | 1.77% | $1.83M |
| Knoll capital management | 455.13K | 1.19% | $169.82K |
| Knott david m jr | 100.00K | 0.26% | $268.00K |
| Lasry marc | 60.87K | 0.16% | $163.13K |
| Marshall wace, llp | 49.47K | 0.13% | $132.57K |
| Y-intercept (hong kong) | 45.45K | 0.12% | $121.80K |
| Newedge advisors | 44.08K | 0.11% | $118.14K |
| Hrt financial lp | 28.22K | 0.07% | $75.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lasry marc | 60.87K | 0.91% | $163.13K |
| Perceptive advisors | 4.59M | 0.46% | $12.31M |
| Rtw investments, lp | 8.31M | 0.32% | $22.26M |
| Knott david m jr | 100.00K | 0.12% | $268.00K |
| Knoll capital management | 455.13K | 0.12% | $169.82K |
| Point72 asia (singapore) pte. | 18.71K | 0.01% | $50.14K |
| Able financial group | 13.40K | 0.01% | $33.24K |
| Y-intercept (hong kong) | 45.45K | 0.00% | $121.80K |
| Xtx topco | 16.82K | 0.00% | $45.07K |
| Newedge advisors | 44.08K | 0.00% | $118.14K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Knoll capital management | 455.13K | 0.12% | 455.13K |
| Knott david m jr | 100.00K | 0.12% | 100.00K |
| Rtw investments, lp | 8.31M | 0.32% | 99.90K |
| Marshall wace, llp | 49.47K | 0.00% | 49.47K |
| Y-intercept (hong kong) | 45.45K | 0.00% | 45.45K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 681.35K | - | -1.26M |
| Bank of new york mellon | - | - | -52.49K |
| Rhumbline advisers | - | - | -31.66K |
| Millennium management | - | - | -21.51K |
| Deutsche bank ag\ | - | - | -20.22K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Knoll capital management | 455.13K | 0.12% | 455.13K | $169.82K |
| Knott david m jr | 100.00K | 0.12% | 100.00K | $268.00K |
| Marshall wace, llp | 49.47K | 0.00% | 49.47K | $132.57K |
| Y-intercept (hong kong) | 45.45K | 0.00% | 45.45K | $121.80K |
| Newedge advisors | 44.08K | 0.00% | 44.08K | $118.14K |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -6.00 |
| Gamma investing | -101.00 |
| Russell investments group | -125.00 |
| Fortitude family office | -203.00 |
| Nisa investment advisors | -241.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 58 | 5.45% | 18,134,637 | -4.51% | 47 | 1.91% | 35 | 52.17% | 16 | -11.11% |
| Mar 31, 2025 | 54 | 8.00% | 18,940,149 | 1.07% | 49 | 2.00% | 22 | -31.25% | 18 | 157.14% |
| Dec 31, 2024 | 52 | 10.64% | 19,199,487 | 0.91% | 51 | 2.00% | 34 | 25.93% | 7 | -22.22% |
| Sep 30, 2024 | 47 | 2.17% | 19,025,949 | 33.83% | 50 | 3.21% | 27 | -10.00% | 9 | 28.57% |
| Jun 30, 2024 | 46 | 9.52% | 14,216,993 | 6.62% | 39 | 2.86% | 30 | 76.47% | 7 | -58.82% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 19, 2025 | Aryeh Jason | - | Buy | $2.45K |
| Aug 25, 2025 | Fain Eric S | - | Buy | $15.03K |
| Aug 25, 2025 | Sherman Darren | See Remarks | Buy | $7.86K |
| Aug 21, 2025 | Hochman David P | See Remarks | Buy | $14.94K |
| Aug 25, 2025 | Taylor Andrew Lawrence | Chief Financial Officer | Buy | $5.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 9 | - |
| 2025 Q2 | 2 | 1 |
| 2025 Q1 | - | - |
| 2024 Q4 | 3 | - |
| 2024 Q3 | 6 | 8 |
OBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools